- Home
- AIN vs SRRK Comparison
AIN vs SRRK Comparison
Compare AIN & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIN
- SRRK
- Stock Information
- Founded
- AIN 1895
- SRRK 2012
- Country
- AIN United States
- SRRK United States
- Employees
- AIN N/A
- SRRK N/A
- Industry
- AIN Textiles
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AIN Consumer Discretionary
- SRRK Health Care
- Exchange
- AIN Nasdaq
- SRRK Nasdaq
- Market Cap
- AIN 2.5B
- SRRK 2.9B
- IPO Year
- AIN 1987
- SRRK 2018
- Fundamental
- Price
- AIN $63.42
- SRRK $30.75
- Analyst Decision
- AIN Buy
- SRRK Strong Buy
- Analyst Count
- AIN 5
- SRRK 6
- Target Price
- AIN $80.40
- SRRK $42.17
- AVG Volume (30 Days)
- AIN 318.6K
- SRRK 1.6M
- Earning Date
- AIN 04-28-2025
- SRRK 05-06-2025
- Dividend Yield
- AIN 1.67%
- SRRK N/A
- EPS Growth
- AIN N/A
- SRRK N/A
- EPS
- AIN 2.80
- SRRK N/A
- Revenue
- AIN $1,230,615,000.00
- SRRK N/A
- Revenue This Year
- AIN $1.49
- SRRK N/A
- Revenue Next Year
- AIN $4.48
- SRRK $601.05
- P/E Ratio
- AIN $22.65
- SRRK N/A
- Revenue Growth
- AIN 7.21
- SRRK N/A
- 52 Week Low
- AIN $57.71
- SRRK $6.76
- 52 Week High
- AIN $95.47
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- AIN 38.10
- SRRK 49.04
- Support Level
- AIN $62.77
- SRRK $28.79
- Resistance Level
- AIN $66.30
- SRRK $31.09
- Average True Range (ATR)
- AIN 3.10
- SRRK 2.50
- MACD
- AIN 0.10
- SRRK 0.44
- Stochastic Oscillator
- AIN 41.29
- SRRK 78.82
About AIN Albany International Corporation
Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.